Delivery Order SPE2DB22D2005-SPE2DB26FJEA9
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 19, 2025, by the Defense Logistics Agency (DLA) for the supply of Mounjaro 2.5 mg/0.5 ml pen injectors. This firm fixed-price delivery order, valued at $4,345.73, is scheduled for completion by September 22, 2025, and will be fulfilled from the vendor's Conshohocken facility. The award was competitively procured with no set-aside designation and represents a child contract under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 22, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors. This competitive award, valued at $7,167.84 with firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX. The ultimate completion date is set for September 23, 2025....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $28,786.43 by the Defense Logistics Agency on September 18, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injectors (0.5 ml). This competitive, firm fixed-price delivery order is non-set-aside and is scheduled for completion by September 19, 2025, with performance taking place at the company's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $25,619.20 by the Defense Logistics Agency on July 18, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors. This firm fixed-price delivery order, which carries an ultimate completion date of July 21, 2025, represents a non-competitive set-aside transaction and will be performed at the company's Corporate Office location in Conshohocken, PA....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Mounjaro 15 mg/0.5 mL pen injectors with a ceiling value of $4,897.62. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 26, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger indefinite delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on May 7, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors valued at $27,363.70, with completion scheduled for May 8, 2025. The order represents a firm fixed-price, competitively awarded delivery against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. Performance will be...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injections, with a contract ceiling value of $1,597.14 and an ultimate completion date of September 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under open competition. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 24, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors, with a ceiling value of $3,265.08. This is a firm fixed-price, non-competitive set-aside delivery order with an ultimate completion date of September 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injectors with a ceiling value of $132,811.30. The contract is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was used in this award, indicating it was competitively awarded. This delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,372.29 by the Defense Logistics Agency (DLA) on June 24, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be completed at the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of June 25, 2025. This delivery order is a child contract issued...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB26FJEA9Delivery Order
AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on October 20, 2025, by the Defense Logistics Agency for the supply of Mounjaro 5 mg/0.5 ml pen injectors. This competitively awarded, non-set-aside contract carries a ceiling value of $1,543.85 and is structured as a firm fixed price delivery order with an ultimate completion date of October 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vendor agreement serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications and medical supplies to support military healthcare programs worldwide. The delivery order for Mounjaro, a diabetes medication, exemplifies the company's role in fulfilling federal medical supply requirements across multiple therapeutic domains for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/20/25 |